New Delhi, India-based Fortis Healthcare is collaborating with U.S.-based TotipotentRX Cell Therapy to set up stem cell therapy centers across its hospitals, according to BIO SmartBrief.

The centers will offer cellular therapies and will undertake stem cell clinical research procedures relating to diabetes, cancer, cardiovascular disease and neurological ischemia, Fortis Healthcare said.

"This allows Fortis to partner with the finest in the field of stem cell therapy and lead the way in this specialized new treatment modality, acknowledged to be at the cutting edge of modern medicine," said Shivinder Mohan Singh, Fortis Healthcare’s managing director.